These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer.
    Author: Costantini CL, Reid TR, Bouvet M.
    Journal: Hepatogastroenterology; 2009; 56(91-92):645-9. PubMed ID: 19621672.
    Abstract:
    Hepatic metastases are common in colorectal cancer. However, only a small percentage of patients are candidates for resection. Neoadjuvant chemotherapy is used to downstage tumors so surgical resection becomes a viable option. We present a case of resection of hepatic metastasis from an 85-year-old patient with metastatic colorectal cancer after treatment with 5-Fluorouracil and 5,10-methylenetetrafolate (CoFactor), an analog of leucovorin, in a Phase II Clinical Trial. CoFactor was developed as a more active replacement of leucovorin to potentially allow reduced dosing of 5-FU. This could potentially be associated with diminished side effects. 5-Fluorouracil with leucovorin or CoFactor could represent another alternative for neoadjuvant chemotherapy prior to resection in metastatic colorectal cancer and warrants further studies, especially in elderly patients.
    [Abstract] [Full Text] [Related] [New Search]